Table 3.
Measures of baseline severity and surgical outcomes of the two groups
| Measure | Group A | Group B |
|---|---|---|
| ODI, % | ||
| Preoperative | 58.2 ± 14.1 | 54.2 ± 12.1 |
| 6 weeks postoperative | 20.3 ± 4.2* | 20.8 ± 3.9* |
| 16 weeks postoperative | 2.2 ± 0.4** | 1.8 ± 0.3** |
| VAS | ||
| Preoperative | 6.1 ± 1.2 | 6.2 ± 1.1 |
| 6 weeks postoperative | 2.5 ± 1.1* | 2.4 ± 1.2* |
| 16 weeks postoperative | 0.7 ± 0.4** | 0.7 ± 0.5** |
| CRP (mg/L) | ||
| Preoperative | 19.2 ± 5.1 | 18.7 ± 5.2 |
| 6 weeks postoperative*** | 9.0 ± 1.9* | 7.1 ± 1.9* |
| 16 weeks postoperative | 3.1 ± 0.5** | 2.7 ± 0.5** |
| ESR (mm/h) | ||
| Preoperative | 39.6 ± 9.9 | 39.1 ± 9.8 |
| 6 weeks postoperative*** | 24.6 ± 1.5* | 16.3 ± 1.1* |
| 16 weeks postoperative | 10.1 ± 1.0** | 9.3 ± 1.1** |
ODI Oswestry Disability Index, VAS visual analog scale, ESR erythrocyte sedimentation rate, CRP C-reactive protein
* P < 0.05 vs. preoperative
** P < 0.05 vs. 6 weeks postoperative
*** P < 0.05, group A vs. group B